|
| 36111991 | Continued Posttrial Benefits of Buprenorphine Extended Release: RECOVER Study Findings. | J Addict Med | 2023 |
| 37245855 | Psychometric properties of the Treatment Effectiveness Assessment in methamphetamine use disorder. | J Subst Use Addict Treat | 2023 |
| 35218405 | Moderation of buprenorphine therapy for cocaine dependence efficacy by variation of the Prodynorphin gene. | Eur J Clin Pharmacol | 2022 |
| 33497547 | Bupropion and Naltrexone in Methamphetamine Use Disorder. | N Engl J Med | 2021 |
| 32289823 | Buprenorphine Maintenance Subjects Are Hyperalgesic and Have No Antinociceptive Response to a Very High Morphine Dose. | Pain Med | 2020 |
| 31952623 | Effects of monthly buprenorphine extended-release injections on patient-centered outcomes: A long-term study. | J Subst Abuse Treat | 2020 |
| 32187112 | Recovery From Opioid Use Disorder (OUD) After Monthly Long-acting Buprenorphine Treatment: 12-Month Longitudinal Outcomes From RECOVER, an Observational Study. | J Addict Med | 2020 |
| 32110137 | An Updated Version of the Treatment Effectiveness Assessment (TEA) [Letter]. | Subst Abuse Rehabil | 2020 |
| 29514333 | Buprenorphine Maintenance Subjects Are Hyperalgesic and Have No Antinociceptive Response to a Very High Morphine Dose. | Pain Med | 2019 |
| 31819701 | Depot Buprenorphine Injection In The Management Of Opioid Use Disorder: From Development To Implementation. | Subst Abuse Rehabil | 2019 |
| 31239805 | Measuring recovery in opioid use disorder: clinical utility and psychometric properties of the Treatment Effectiveness Assessment. | Subst Abuse Rehabil | 2019 |
| 30724759 | Medication Adherence Monitoring Using Smartphone Video Dosing in an Open-label Pilot Study of Monthly Naltrexone Plus Once-daily Bupropion for Methamphetamine Use Disorder: Feasibility and Acceptability. | J Addict Med | 2019 |
| 30844878 | Patient-centered Outcomes in Participants of a Buprenorphine Monthly Depot (BUP-XR) Double-blind, Placebo-controlled, Multicenter, Phase 3 Study. | J Addict Med | 2019 |
| 30460781 | Treatment of opioid dependence with buprenorphine/naloxone sublingual tablets: A phase 3 randomized, double-blind, placebo-controlled trial. | Asia Pac Psychiatry | 2019 |
| 30508592 | Remission from chronic opioid use-Studying environmental and socio-economic factors on recovery (RECOVER): Study design and participant characteristics. | Contemp Clin Trials | 2019 |
| 27958381 | A polymorphism in the OPRM1 3'-untranslated region is associated with methadone efficacy in treating opioid dependence. | Pharmacogenomics J | 2018 |
| 29672167 | Sex differences in opioid use and medical issues during buprenorphine/naloxone treatment. | Am J Drug Alcohol Abuse | 2018 |
| 27898496 | Distinctive Trajectories of Opioid Use Over an Extended Follow-up of Patients in a Multisite Trial on Buprenorphineâ¿¿+â¿¿Naloxone and Methadone. | J Addict Med | 2017 |
| 28363323 | Prescription opioid addiction and chronic pain: More than a feeling. | Drug Alcohol Depend | 2017 |
| 28164407 | Volatility and change in chronic pain severity predict outcomes of treatment for prescription opioid addiction. | Addiction | 2017 |
| 28867267 | Testing and linkage to HIV care in China: a cluster-randomised trial. | Lancet HIV | 2017 |
| 28606085 | Care cascade structural intervention versus standard of care in the diagnosis and treatment of HIV in China: a cluster-randomized controlled trial protocol. | BMC Health Serv Res | 2017 |
| 26948856 | Buprenorphine + naloxone plus naltrexone for the treatment of cocaine dependence: the Cocaine Use Reduction with Buprenorphine (CURB) study. | Addiction | 2016 |
| 26599131 | Long-term outcomes after randomization to buprenorphine/naloxone versus methadone in a multi-site trial. | Addiction | 2016 |
| 27768710 | Loss to Follow-Up from HIV Screening to ART Initiation in Rural China. | PLoS One | 2016 |
| 27612968 | Dose, Plasma Level, and Treatment Outcome Among Methadone Patients in Shanghai, China. | Neurosci Bull | 2016 |
| 27379819 | Utilizing a Two-stage Design to Investigate the Safety and Potential Efficacy of Monthly Naltrexone Plus Once-daily Bupropion as a Treatment for Methamphetamine Use Disorder. | J Addict Med | 2016 |
| 27521809 | NIDA Clinical Trials Network CTN-0051, Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment (X:BOT): Study design and rationale. | Contemp Clin Trials | 2016 |
| 27282118 | Injectable pharmacotherapy for opioid use disorders (IPOD). | Contemp Clin Trials | 2016 |
| 27008037 | A Perspective on Opioid Pharmacotherapy: Where We Are and How We Got Here. | J Neuroimmune Pharmacol | 2016 |
| 25065489 | Buprenorphine pharmacotherapy and behavioral treatment: comparison of outcomes among prescription opioid users, heroin users and combination users. | J Subst Abuse Treat | 2015 |
| 26302337 | Pain volatility and prescription opioid addiction treatment outcomes in patients with chronic pain. | Exp Clin Psychopharmacol | 2015 |
| 26511766 | Short term health-related quality of life improvement during opioid agonist treatment. | Drug Alcohol Depend | 2015 |
| 26107818 | Efficacy of Cognitive Behavioral Therapy on Opiate Use and Retention in Methadone Maintenance Treatment in China: A Randomised Trial. | PLoS One | 2015 |
| 25908321 | Examining the factor structure of the Clinical Opiate Withdrawal Scale: A secondary data analysis from the National Drug Abuse Treatment Clinical Trials Network (CTN) 0003. | Drug Alcohol Depend | 2015 |
| 25901451 | Treating Opioid Dependence With Injectable Extended-Release Naltrexone (XR-NTX): Who Will Respond? | J Addict Med | 2015 |
| 25622776 | Using behavioral economics to predict opioid use during prescription opioid dependence treatment. | Drug Alcohol Depend | 2015 |
| 25814381 | Risk Factors Associated with HCV Among Opioid-Dependent Patients in a Multisite Study. | J Community Health | 2015 |
| 25747921 | Long-term course of opioid addiction. | Harv Rev Psychiatry | 2015 |
| 25322681 | Conversation with Walter Ling. | Addiction | 2015 |
| 23961726 | Treatment retention among patients randomized to buprenorphine/naloxone compared to methadone in a multi-site trial. | Addiction | 2014 |
| 25591636 | [Injectable extended-release naltrexone for opioid dependence: an open label study of long-term safety and efficacy]. | Zh Nevrol Psikhiatr Im S S Korsakova | 2014 |
| 25243431 | Authors' reply: "Risk reduction with buprenorphine-naloxone and methadone: patient's choice". | J Acquir Immune Defic Syndr | 2014 |
| 25364994 | Patient perspectives on buprenorphine/naloxone: a qualitative study of retention during the starting treatment with agonist replacement therapies (START) study. | J Psychoactive Drugs | 2014 |
| 24751432 | HIV risk reduction with buprenorphine-naloxone or methadone: findings from a randomized trial. | J Acquir Immune Defic Syndr | 2014 |
| 24825486 | Sustained-release methylphenidate in a randomized trial of treatment of methamphetamine use disorder. | Addiction | 2014 |
| 24126707 | Genetic variation in OPRD1 and the response to treatment for opioid dependence with buprenorphine in European-American females. | Pharmacogenomics J | 2014 |
| 24112096 | The relationship between primary prescription opioid and buprenorphine-naloxone induction outcomes in a prescription opioid dependent sample. | Am J Addict | 2014 |
| 22921476 | Buprenorphine/Naloxone and methadone effects on laboratory indices of liver health: a randomized trial. | Drug Alcohol Depend | 2013 |
| 25264415 | Medication-assisted therapy for opioid addiction. | J Food Drug Anal | 2013 |